Dr Vasiljević učesnik je najznačajnijih medjunarodnih kliničkih studija, autor i koautor velikog broja naučnih radova iz sledećih polja ekspertize: Lečenje akutnih i hroničnih oboljenja pluća, COPD, sistemskih bolesti pluća, bolesti alergijsko- imunološke etiologije, astme, tuberkuloze, malignih bolesti pluća i plućne tromboembolije.
-CE01-301 randomized double-blind multi-center study to evaluate the efficacy and safety of i.v. to oral Solithromycin (CEM- 101) compared to i.v. to oral Moxifloxacin in the treatment of bacterial pneumonia
-NEPA 15-18 A phase 3 multicenter , randomized, double blind active control study to evaluate the safety and the efficacy of i.v. pro-netupitant /palonosetron combination for the prevention of HT induced nausea and vomiting
-TERRANOVA randomized double-blind dummy chronic dosing (56 week) placebo-controlled parallel group multicentre phase III study to evaluate the efficacy and safety of 3 dose of Benralizumab (MEDI-563) in patient with moderate to very severe COPD with o history of COPD exacerbation
-ML (3341-306)- A phase 3 multicenter randomized double- blind comparation controlled study to evaluate the safety and efficacy of i.v. to oral Delafloxacin in adult subjects with CABP
-NABRIVA Phase 3, Randomized, Double-Blind, Double Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC-3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia
-JAVELIN-A phase III open-label multicenter trial of Avelumab (MSB0010718C) versus platinum based doublet as a first-line treatment of recurrent of Stage IV PD-L1+ non-small cell lung cancer
